Unknown

Dataset Information

0

Defining the 3'Epigenetic Boundary of the FMR1 Promoter and Its Loss in Individuals with Fragile X Syndrome.


ABSTRACT: This study characterizes the DNA methylation patterns specific to fragile X syndrome (FXS) with a full mutation (FM > 200 CGGs), premutation (PM 55-199 CGGs), and X inactivation in blood and brain tissues at the 3' boundary of the FMR1 promoter. Blood was analyzed from 95 controls and 462 individuals (32% males) with FM and PM alleles. Brain tissues (62% males) were analyzed from 12 controls and 4 with FXS. There was a significant increase in intron 1 methylation, extending to a newly defined 3' epigenetic boundary in the FM compared with that in the control and PM groups (p < 0.0001), and this was consistent between the blood and brain tissues. A distinct intron 2 site showed a significant decrease in methylation for the FXS groups compared with the controls in both sexes (p < 0.01). In all female groups, most intron 1 (but not intron 2 sites) were sensitive to X inactivation. In all PM groups, methylation at the 3' epigenetic boundary and the proximal sites was significantly decreased compared with that in the control and FM groups (p < 0.0001). In conclusion, abnormal FMR1 intron 1 and 2 methylation that was sensitive to X inactivation in the blood and brain tissues provided a novel avenue for the detection of PM and FM alleles through DNA methylation analysis.

SUBMITTER: Godler DE 

PROVIDER: S-EPMC10342127 | biostudies-literature | 2023 Jun

REPOSITORIES: biostudies-literature

altmetric image

Publications

Defining the 3'Epigenetic Boundary of the <i>FMR1</i> Promoter and Its Loss in Individuals with Fragile X Syndrome.

Godler David E DE   Inaba Yoshimi Y   Bui Minh Q MQ   Francis David D   Skinner Cindy C   Schwartz Charles E CE   Amor David J DJ  

International journal of molecular sciences 20230627 13


This study characterizes the DNA methylation patterns specific to fragile X syndrome (FXS) with a full mutation (FM > 200 CGGs), premutation (PM 55-199 CGGs), and X inactivation in blood and brain tissues at the 3' boundary of the <i>FMR1</i> promoter. Blood was analyzed from 95 controls and 462 individuals (32% males) with FM and PM alleles. Brain tissues (62% males) were analyzed from 12 controls and 4 with FXS. There was a significant increase in intron 1 methylation, extending to a newly def  ...[more]

Similar Datasets

| S-EPMC2775827 | biostudies-literature
| S-EPMC6078593 | biostudies-literature
| S-EPMC4956488 | biostudies-literature
| S-EPMC4357282 | biostudies-literature
| S-EPMC3166088 | biostudies-literature
| S-EPMC3060329 | biostudies-literature
| S-EPMC5808132 | biostudies-literature
2025-07-16 | GSE271271 | GEO
| S-EPMC9849779 | biostudies-literature